Rang	Name	Position
1	Mr. Benjamin L. Palleiko	CEO & Director
2	Mr. Brian Piekos	Chief Financial Officer
3	Mr. Bilal Arif	Chief Operating Officer
4	Dr. Paul K. Audhya M.B.A., M.D.	Chief Medical Officer
5	Mr. Ryan Baker	Head of Investor Relations
6	Mr. Brian Krex J.D.	General Counsel
7	Dr. Christopher L. Hamblett Ph.D.	Senior Vice President of Corporate Development
8	Ms. Linea Aspesi	Chief People Officer
9	Ms. Rachel M. Morten	Senior Vice President of Regulatory Affairs & QA
10	Dr. Christopher M. Yea Ph.D.	Chief Development Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	VR Adviser, LLC	12,16%	0,18 Mrd. USD
2	Frazier Life Sciences Management, L.P.	9,32%	0,13 Mrd. USD
3	Suvretta Capital Management, LLC	8,96%	0,13 Mrd. USD
4	TANG CAPITAL MANAGEMENT LLC	8,59%	0,12 Mrd. USD
5	BlackRock Inc	7,13%	0,10 Mrd. USD
6	SILVERARC CAPITAL MANAGEMENT, LLC	5,40%	0,08 Mrd. USD
7	Capital World Investors	5,28%	0,08 Mrd. USD
8	Vanguard Group Inc	4,71%	0,07 Mrd. USD
9	Point72 Asset Management, L.P.	4,01%	0,06 Mrd. USD
10	State Street Corp	3,67%	0,05 Mrd. USD
11	Millennium Management LLC	3,59%	0,05 Mrd. USD
12	Vestal Point Capital LP	3,47%	0,05 Mrd. USD
13	Parkman Healthcare Partners LLC	3,45%	0,05 Mrd. USD
14	Vanguard Capital Management, LLC	3,44%	0,05 Mrd. USD
15	Kynam Capital Management, LP	3,42%	0,05 Mrd. USD
16	Woodline Partners LP	2,84%	0,04 Mrd. USD
17	Octagon Capital Advisors LP	2,72%	0,04 Mrd. USD
18	Squadron Capital Management LLC	2,44%	0,04 Mrd. USD
19	Emerald Advisers, LLC	2,37%	0,03 Mrd. USD
20	Armistice Capital, LLC	2,32%	0,03 Mrd. USD